EXTAVIA
Dead / Cancelled — Cancelled — Section 8 (as of 17 Sept 2010)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78221165
- Registration number
- 2813082
- Mark type
- Word mark
- Filed
- 04 Mar 2003
- Published for opposition
- 18 Nov 2003
- Registered
- 10 Feb 2004
- Attorney of record
- Steven H. Hartman
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for prevention and/or treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, and for use in the gastroenterological area
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 17 Sept 2010 — CANCELLED SEC. 8 (6-YR)
- 15 Dec 2009 — REVIEW OF CORRESPONDENCE COMPLETE
- 14 Dec 2009 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Jun 2009 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Jun 2009 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Dec 2004 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Dec 2004 — PAPER RECEIVED
- 10 Feb 2004 — REGISTERED-PRINCIPAL REGISTER
- 18 Nov 2003 — PUBLISHED FOR OPPOSITION
- 29 Oct 2003 — NOTICE OF PUBLICATION
- 25 Sept 2003 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Sept 2003 — Sec. 1(B) CLAIM DELETED
- 02 Sept 2003 — Sec. 1(B) CLAIM DELETED
- 02 Sept 2003 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Sept 2003 — PAPER RECEIVED